Cambridge, MA, February 25, 2026—Harvard Law’s Petrie-Flom Center has published Mauritz Kop’s new article, Hippocratic Quantum: The Ethics of Biomedical Discovery in the Quantum Age:https://petrieflom.law.harvard.edu/2026/02/25/hippocratic-quantum-the-ethics-of-biomedical-discovery-in-the-quantum-age/
The article advances a proposition that is becoming increasingly difficult for health lawyers, policymakers, and biomedical innovators to ignore: as quantum technologies begin to enter biomedical discovery, the decisive challenge is no longer only scientific capability, but rather governance. In Kop’s account, quantum-enabled medicine should not be understood as a distant or speculative frontier that can be regulated later, once the engineering settles. It should instead be approached as a present-tense quantum governance problem, one that already implicates patient confidentiality, data integrity, cyber resilience, export controls, supply chains, and the geostrategic value of biomedical knowledge.
The article’s answer is not a new morality, but a more demanding implementation of an existing one: quantum medicine requires a Hippocratic framework that is technical enough for engineers, legal enough for regulators, and concrete enough for hospitals and pharmaceutical firms, yet flexible enough to let innovation breathe and encourage the crucial public-private investment necessary to advance allied quantum capabilities.
Five examples of quantum-enabled biomedical innovations
To ground this institutional view, one must consider the specific technological capabilities currently transitioning from theoretical physics to applied biomedicine. Five feasible vectors of innovation illustrate the breadth of this shift. In the domain of quantum computing, hybrid classical-quantum algorithms are emerging to optimize complex drug discovery pipelines and process large-scale genomic datasets. In quantum sensing, technologies such as diamond nitrogen-vacancy magnetometry enable ultra-sensitive, room-temperature mapping of neurological and cardiac activity. For quantum simulation, researchers are utilizing qubit-based systems to model molecular interactions and drug-target binding affinities with high accuracy, aiming to reduce reliance on extensive physical wet-lab screening. Within quantum imaging, techniques leveraging entangled photons permit the high-resolution visualization of cellular structures at lower light intensities, thereby mitigating phototoxicity in living tissues, benefitting medical diagnosis. Finally, in quantum networking, the deployment of quantum key distribution protocols offers a mechanism to cryptographically secure the transmission of sensitive multi-omics data across distributed hospital and research architectures.
From legal-ethical framework to Quantum-ELSPI
The Harvard article is best read as part of a longer intellectual trajectory. An early expression of that project appeared in March 2021 in the Yale Journal of Law & Technology, in Establishing a Legal-Ethical Framework for Quantum Technology: https://yjolt.org/blog/establishing-legal-ethical-framework-quantum-technology
That Yale piece argued that quantum technologies were moving from hypothetical ideas to commercial realities, and that law and policy should not wait for full technical maturity before building governance tools. It proposed a culturally sensitive legal-ethical framework for applied quantum technologies, drawing on AI governance and nanotechnology’s ELSI tradition while recognizing the distinct physical characteristics of quantum systems. Crucially, it also insisted that ethical aspiration must be accompanied by practical mechanisms for monitoring, validation, and life-cycle risk management. In retrospect, many of the themes that now reappear in Hippocratic Quantum were already visible there: the concern for human-centered design, the call for risk-based governance, and the insistence that ethics without institutionalization would be inadequate.
Why quantum medicine changes the governance question
The new Harvard article narrows the focus to biomedicine, but in doing so it sharpens the stakes. Biomedical discovery is not simply another application area. It is a setting in which long-lived and highly sensitive data, bodily integrity, public-health interests, commercial incentives, and geopolitical competition intersect. Quantum technologies matter here not because they promise speculative disruption, but because they may incrementally and then materially improve specific tasks: hybrid quantum-classical computational chemistry, de novo molecular design, lead optimization, selected toxicity and metabolism modeling, and perhaps aspects of high-fidelity sensing, simulation, and networked quantum computation. The issue, then, is not whether every promise will be realized immediately. It is whether institutions are preparing now for the forms of capability that are already foreseeable.
A Harvard-facing research arc
This Harvard publication also extends a longer Harvard-facing research arc across AI, health law, and responsible quantum governance. That arc includes:
The Right To Process Data For Machine Learning Purposes In The EU (Harvard JOLT) https://jolt.law.harvard.edu/digest/the-right-to-process-data-for-machine-learning-purposes-in-the-eu
Towards Responsible Quantum Technology (Harvard Berkman Klein) https://cyber.harvard.edu/publication/2023/towards-responsible-quantum-technology
EU And US Regulatory Challenges Facing AI Health Care Innovator Firms (Harvard Petrie-Flom) https://petrieflom.law.harvard.edu/2024/04/04/eu-and-us-regulatory-challenges-facing-ai-health-care-innovator-firms/
A Brief Quantum Medicine Policy Guide (Harvard Petrie-Flom) https://petrieflom.law.harvard.edu/2024/12/06/a-brief-quantum-medicine-policy-guide/
How Quantum Technologies May Be Integrated Into Healthcare: What Regulators Should Consider (Stanford Law) https://hls.harvard.edu/bibliography/how-quantum-technologies-may-be-integrated-into-healthcare-what-regulators-should-consider/
Seen in this broader context, Hippocratic Quantum brings together early legal-ethical framing, responsible quantum governance, healthcare regulation, and geopolitical analysis into a single biomedical governance argument.
Meer lezen